Research Code:MRHC - 104265
Sku:MRHC - 104265
Cell isolation or separation is a tool used to sort cells into specific population from heterogeneous group of cells without contamination. The isolation of cells depends on properties of cells such as surface charge and adhesion, cell size and density, surface markers, and few others. The use of cell isolation techniques helps to open the door of cell-based therapies and thereby improve the quality of treatment and clinical outcome. Factors such as increasing incidence & prevalence of chronic diseases with aging population, technological advancement in cell isolation, growing demand for biopharmaceuticals and personalized medicine, and increasing stem cell research are driving cell isolation/cell separation market. Moreover, Asian countries and growing use of microfluidics technology will provide high opportunities for this market during forecast period. On the other hand, ethical issues regarding isolation of embryonic stem cells and high cost of cell separation instruments are expected to restrict the growth of this market.
Hurry Up To Get Your Free Sample Report Now!
https://www.meticulousresearch.com/request-sample-report/cp_id=4966
Key Players in the Cell Isolation/Cell Separation Market
Vendors are moving towards launching of new products along with technological advancement. For instance, in April 2018, Merck KGaA (Germany) launched CellStream benchtop flow cytometry system. This system provides greater sensitivity and allows scientists to tailor their instrument to their needs in immunology, cancer research and many other areas. Moreover, in 2016, QIAGEN N.V. launched QIAscout for isolation of viable single cells from samples for next-generation sequencing (NGS), polymerase chain reaction (PCR) and other downstream applications.
Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany), Miltenyi Biotec (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), Terumo BCT, Inc. (U.S.), STEMCELL Technologies Inc. (Canada), pluriSelect Life Science UG & Co. KG (Germany), and Takara Bio Inc. (Japan) are some of the key players operating in this market.
Potential Market Analysis
The cell isolation/cell separation market is segmented by product [consumables (reagents and kits, beads and microspheres, media and sera, disposables), instruments (centrifuges, filtration systems, flow cytometer, magnetic-activated cell sorter)], cell type (human cells, animal cells, and others), technology (centrifugation, filtration, surface marker cell isolation), application (isolation of biomolecules, research, diagnostics, therapeutics, and others), end user (pharmaceutical & biotechnology companies, hospitals and diagnostic labs, academic and research institutes, and cell banks), and geography.
Based on product, consumables accounted for the largest share of global cell isolation/cell separation market in 2018 due to their repeated usage and procurement for various applications such as research, diagnostics, therapeutics, and others.
On the basis of cell type, human cells are expected to grow at fastest rate owing to growing number of chronic diseases and advancement in cell isolation techniques.
Based on application, isolation of biomolecules accounted for the largest share of global cell isolation/cell separation market in 2018. This is mainly due to increasing investment in biopharmaceutical production and personalized medicines by various end users.
On the basis of geographical analysis, North America including U.S. and Canada is anticipating being the largest market due to well-established healthcare system in the region, higher acceptance of advanced technologies, raising non-communicable diseases, rise in pharmaceutical & biotech research, higher stem cell research funding, and presence of key players. Moreover, Asia Pacific is expected to grow at fastest CAGR due to rapidly developing economies, growing aging population coupled with the rising prevalence of chronic diseases, on-going capacity expansions by pharmaceutical & biotechnology manufacturers, and investment from government & non-government bodies in biotechnology sector.
Potential of Market
Stem cell based research is continuously growing by passing various hurdles. Moreover, researchers have been scaled back their use of animal models as these stem cells give better path for studying human diseases. The cell based diagnostic tool offers a more accurate representation of the real-life model than animal-based model. Also, it reduces the time span and expenses in drug discovery compared to animal-based diagnosis. Thus, their potential will lead to reshape the biological concepts and start to move them into clinic within next few years.
Key questions answered in the report:
Growing penetration of cell isolation/cell separation consumables & instruments in developing countries will propel the overall cell isolation/cell separation market
Pharmaceutical & biotechnology companies account for the largest share of the cell isolation/cell separation market, globally
Cell isolation/cell separation market favors both larger and local manufacturers that compete in multiple segments
Recent partnerships, acquisitions, and expansions have taken place in the global cell isolation/cell separation market
1 Introduction to Cell Isolation/Cell Separation Market
1.1 Market Ecosystem
1.2 Definition
1.3 Years Considered in study
1.4 Currency and Limitations
1.5 Market Buzz and Foregrounds
2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Analytics
3 Executive Summary
4 Market Insights
4.1 Drivers
4.1.1 Increasing Incidence & Prevalence of Chronic Diseases with Aging Population
4.1.2 Technological Advancement in Cell Isolation
4.1.3 Growing Demand for Biopharmaceuticals and Personalized Medicine
4.1.4 Increasing Stem Cell Research
4.2 Restraint
4.2.1 Ethical Issues Regarding Isolation of Embryonic Stem Cells
4.2.2 High cost of Cell Separation Instruments
4.3 Opportunities
4.3.1 Emerging Opportunities from Asian Countries
4.3.2 Growing Use of Microfluidics Technology
4.4 Challenges
4.4.1 Handling and Optimization of Protocol for in-vitro Study
5 Cell Isolation/Cell Separation Market, by Product
5.1 Introduction
5.2 Consumables
5.2.1 Reagents and Kits
5.2.2 Beads and Microspheres
5.2.3 Media and Sera
5.2.4 Disposables
5.3 Instruments
5.3.1 Centrifuges
5.3.1.1 Benchtop Centrifuge
5.3.1.2 Ultracentrifuge
5.3.2 Filtration Systems
5.3.3 Flow Cytometer
5.3.4 Magnetic-activated Cell Sorter
5.3.4.1 Manual
5.3.4.2 Automatic
6 Cell Isolation/Cell Separation Market, by Cell Type
6.1 Introduction
6.2 Human Cells
6.2.1 Bone Marrow
6.2.2 Adipose Tissue
6.2.3 Cord Blood/Embryonic Stem Cells
6.3 Animal Cells
6.3.1 Bone Marrow
6.3.2 Adipose Tissue
6.3.3 Cord Blood/Embryonic Stem Cells
6.4 Plant Cells
6.5 Others
7 Cell Isolation/Cell Separation Market, by Technology
7.1 Introduction
7.2 Centrifugation Based Cell Separation
7.3 Filtration Based Cell Separation
7.4 Surface Marker Cell Isolation
8 Cell Isolation/Cell Separation Market, by Application
8.1 Introduction
8.2 Isolation of Biomolecules
8.3 Research
8.3.1 Cancer Research
8.3.2 Stem Cell Research
8.4 Diagnostics
8.5 Therapeutics
8.6 Others
9 Cell Isolation/Cell Separation Market, by End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Hospitals and Diagnostic Labs
9.4 Academic and Research Institutes
9.5 Cell Banks
10 Cell Isolation/Cell Separation Market, by Geography
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 RoE
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 RoAPAC
10.5 Rest of World
10.5.1 Latin America
10.5.2 Middle East & Africa
11 Competitive Landscape
12 Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.2 GE Healthcare
12.3 Bio-Rad Laboratories
12.4 Merck KGaA
12.5 Becton, Dickinson and Company
12.6 Miltenyi Biotec
12.7 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
12.8 Terumo Bct, Inc.
12.9 pluriSelect Life Science
12.10 Stemcell Technologies Inc.
12.11 Takara Bio Inc.
13 Appendix
13.1 Questionnaire
This website is secure and we do not share your personal information with any third party. Privacy Policy
Cell isolation or separation is a tool used to sort cells into specific population from heterogeneous group of cells without contamination. The isolation of cells depends on properties of cells such as surface charge and adhesion, cell size and density, surface markers, and few others. The use of cell isolation techniques helps to open the door of cell-based therapies and thereby improve the quality of treatment and clinical outcome. Factors such as increasing incidence & prevalence of chronic diseases with aging population, technological advancement in cell isolation, growing demand for biopharmaceuticals and personalized medicine, and increasing stem cell research are driving cell isolation/cell separation market. Moreover, Asian countries and growing use of microfluidics technology will provide high opportunities for this market during forecast period. On the other hand, ethical issues regarding isolation of embryonic stem cells and high cost of cell separation instruments are expected to restrict the growth of this market.
Hurry Up To Get Your Free Sample Report Now!
https://www.meticulousresearch.com/request-sample-report/cp_id=4966
Key Players in the Cell Isolation/Cell Separation Market
Vendors are moving towards launching of new products along with technological advancement. For instance, in April 2018, Merck KGaA (Germany) launched CellStream benchtop flow cytometry system. This system provides greater sensitivity and allows scientists to tailor their instrument to their needs in immunology, cancer research and many other areas. Moreover, in 2016, QIAGEN N.V. launched QIAscout for isolation of viable single cells from samples for next-generation sequencing (NGS), polymerase chain reaction (PCR) and other downstream applications.
Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany), Miltenyi Biotec (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), Terumo BCT, Inc. (U.S.), STEMCELL Technologies Inc. (Canada), pluriSelect Life Science UG & Co. KG (Germany), and Takara Bio Inc. (Japan) are some of the key players operating in this market.
Potential Market Analysis
The cell isolation/cell separation market is segmented by product [consumables (reagents and kits, beads and microspheres, media and sera, disposables), instruments (centrifuges, filtration systems, flow cytometer, magnetic-activated cell sorter)], cell type (human cells, animal cells, and others), technology (centrifugation, filtration, surface marker cell isolation), application (isolation of biomolecules, research, diagnostics, therapeutics, and others), end user (pharmaceutical & biotechnology companies, hospitals and diagnostic labs, academic and research institutes, and cell banks), and geography.
Based on product, consumables accounted for the largest share of global cell isolation/cell separation market in 2018 due to their repeated usage and procurement for various applications such as research, diagnostics, therapeutics, and others.
On the basis of cell type, human cells are expected to grow at fastest rate owing to growing number of chronic diseases and advancement in cell isolation techniques.
Based on application, isolation of biomolecules accounted for the largest share of global cell isolation/cell separation market in 2018. This is mainly due to increasing investment in biopharmaceutical production and personalized medicines by various end users.
On the basis of geographical analysis, North America including U.S. and Canada is anticipating being the largest market due to well-established healthcare system in the region, higher acceptance of advanced technologies, raising non-communicable diseases, rise in pharmaceutical & biotech research, higher stem cell research funding, and presence of key players. Moreover, Asia Pacific is expected to grow at fastest CAGR due to rapidly developing economies, growing aging population coupled with the rising prevalence of chronic diseases, on-going capacity expansions by pharmaceutical & biotechnology manufacturers, and investment from government & non-government bodies in biotechnology sector.
Potential of Market
Stem cell based research is continuously growing by passing various hurdles. Moreover, researchers have been scaled back their use of animal models as these stem cells give better path for studying human diseases. The cell based diagnostic tool offers a more accurate representation of the real-life model than animal-based model. Also, it reduces the time span and expenses in drug discovery compared to animal-based diagnosis. Thus, their potential will lead to reshape the biological concepts and start to move them into clinic within next few years.
Key questions answered in the report:
Growing penetration of cell isolation/cell separation consumables & instruments in developing countries will propel the overall cell isolation/cell separation market
Pharmaceutical & biotechnology companies account for the largest share of the cell isolation/cell separation market, globally
Cell isolation/cell separation market favors both larger and local manufacturers that compete in multiple segments
Recent partnerships, acquisitions, and expansions have taken place in the global cell isolation/cell separation market
1 Introduction to Cell Isolation/Cell Separation Market
1.1 Market Ecosystem
1.2 Definition
1.3 Years Considered in study
1.4 Currency and Limitations
1.5 Market Buzz and Foregrounds
2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Analytics
3 Executive Summary
4 Market Insights
4.1 Drivers
4.1.1 Increasing Incidence & Prevalence of Chronic Diseases with Aging Population
4.1.2 Technological Advancement in Cell Isolation
4.1.3 Growing Demand for Biopharmaceuticals and Personalized Medicine
4.1.4 Increasing Stem Cell Research
4.2 Restraint
4.2.1 Ethical Issues Regarding Isolation of Embryonic Stem Cells
4.2.2 High cost of Cell Separation Instruments
4.3 Opportunities
4.3.1 Emerging Opportunities from Asian Countries
4.3.2 Growing Use of Microfluidics Technology
4.4 Challenges
4.4.1 Handling and Optimization of Protocol for in-vitro Study
5 Cell Isolation/Cell Separation Market, by Product
5.1 Introduction
5.2 Consumables
5.2.1 Reagents and Kits
5.2.2 Beads and Microspheres
5.2.3 Media and Sera
5.2.4 Disposables
5.3 Instruments
5.3.1 Centrifuges
5.3.1.1 Benchtop Centrifuge
5.3.1.2 Ultracentrifuge
5.3.2 Filtration Systems
5.3.3 Flow Cytometer
5.3.4 Magnetic-activated Cell Sorter
5.3.4.1 Manual
5.3.4.2 Automatic
6 Cell Isolation/Cell Separation Market, by Cell Type
6.1 Introduction
6.2 Human Cells
6.2.1 Bone Marrow
6.2.2 Adipose Tissue
6.2.3 Cord Blood/Embryonic Stem Cells
6.3 Animal Cells
6.3.1 Bone Marrow
6.3.2 Adipose Tissue
6.3.3 Cord Blood/Embryonic Stem Cells
6.4 Plant Cells
6.5 Others
7 Cell Isolation/Cell Separation Market, by Technology
7.1 Introduction
7.2 Centrifugation Based Cell Separation
7.3 Filtration Based Cell Separation
7.4 Surface Marker Cell Isolation
8 Cell Isolation/Cell Separation Market, by Application
8.1 Introduction
8.2 Isolation of Biomolecules
8.3 Research
8.3.1 Cancer Research
8.3.2 Stem Cell Research
8.4 Diagnostics
8.5 Therapeutics
8.6 Others
9 Cell Isolation/Cell Separation Market, by End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Hospitals and Diagnostic Labs
9.4 Academic and Research Institutes
9.5 Cell Banks
10 Cell Isolation/Cell Separation Market, by Geography
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 RoE
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 RoAPAC
10.5 Rest of World
10.5.1 Latin America
10.5.2 Middle East & Africa
11 Competitive Landscape
12 Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.2 GE Healthcare
12.3 Bio-Rad Laboratories
12.4 Merck KGaA
12.5 Becton, Dickinson and Company
12.6 Miltenyi Biotec
12.7 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
12.8 Terumo Bct, Inc.
12.9 pluriSelect Life Science
12.10 Stemcell Technologies Inc.
12.11 Takara Bio Inc.
13 Appendix
13.1 Questionnaire
1 Introduction to Cell Isolation/Cell Separation Market
1.1 Market Ecosystem
1.2 Definition
1.3 Years Considered in study
1.4 Currency and Limitations
1.5 Market Buzz and Foregrounds
2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Market Analytics
3 Executive Summary
4 Market Insights
4.1 Drivers
4.1.1 Increasing Incidence & Prevalence of Chronic Diseases with Aging Population
4.1.2 Technological Advancement in Cell Isolation
4.1.3 Growing Demand for Biopharmaceuticals and Personalized Medicine
4.1.4 Increasing Stem Cell Research
4.2 Restraint
4.2.1 Ethical Issues Regarding Isolation of Embryonic Stem Cells
4.2.2 High cost of Cell Separation Instruments
4.3 Opportunities
4.3.1 Emerging Opportunities from Asian Countries
4.3.2 Growing Use of Microfluidics Technology
4.4 Challenges
4.4.1 Handling and Optimization of Protocol for in-vitro Study
5 Cell Isolation/Cell Separation Market, by Product
5.1 Introduction
5.2 Consumables
5.2.1 Reagents and Kits
5.2.2 Beads and Microspheres
5.2.3 Media and Sera
5.2.4 Disposables
5.3 Instruments
5.3.1 Centrifuges
5.3.1.1 Benchtop Centrifuge
5.3.1.2 Ultracentrifuge
5.3.2 Filtration Systems
5.3.3 Flow Cytometer
5.3.4 Magnetic-activated Cell Sorter
5.3.4.1 Manual
5.3.4.2 Automatic
6 Cell Isolation/Cell Separation Market, by Cell Type
6.1 Introduction
6.2 Human Cells
6.2.1 Bone Marrow
6.2.2 Adipose Tissue
6.2.3 Cord Blood/Embryonic Stem Cells
6.3 Animal Cells
6.3.1 Bone Marrow
6.3.2 Adipose Tissue
6.3.3 Cord Blood/Embryonic Stem Cells
6.4 Plant Cells
6.5 Others
7 Cell Isolation/Cell Separation Market, by Technology
7.1 Introduction
7.2 Centrifugation Based Cell Separation
7.3 Filtration Based Cell Separation
7.4 Surface Marker Cell Isolation
8 Cell Isolation/Cell Separation Market, by Application
8.1 Introduction
8.2 Isolation of Biomolecules
8.3 Research
8.3.1 Cancer Research
8.3.2 Stem Cell Research
8.4 Diagnostics
8.5 Therapeutics
8.6 Others
9 Cell Isolation/Cell Separation Market, by End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Hospitals and Diagnostic Labs
9.4 Academic and Research Institutes
9.5 Cell Banks
10 Cell Isolation/Cell Separation Market, by Geography
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 RoE
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 RoAPAC
10.5 Rest of World
10.5.1 Latin America
10.5.2 Middle East & Africa
11 Competitive Landscape
12 Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.2 GE Healthcare
12.3 Bio-Rad Laboratories
12.4 Merck KGaA
12.5 Becton, Dickinson and Company
12.6 Miltenyi Biotec
12.7 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
12.8 Terumo Bct, Inc.
12.9 pluriSelect Life Science
12.10 Stemcell Technologies Inc.
12.11 Takara Bio Inc.
13 Appendix
13.1 Questionnaire